Abstract: Bacopa monnieri belonging to family Scrophulariaceae has been used since time immemorial by Ayurvedic medical practitioners in India as brain tonic. In the present clinical trial, efficacy of BacoMind®, an enriched phytochemical composition from Bacopa monnieri on cognitive function in children requiring individual education programme was evaluated. Twenty-eight volunteers with Intelligent Quotient between 70-90 were enrolled in the clinical trial. The study was conducted as outpatient procedure in hospital settings with close monitoring. BacoMind® at 225 mg as single oral dose for a duration of four months showed significant change in the baseline value of working memory and short term verbal memory from 5.21±0.32 to 6.38±0.25 (p≤0.05) and 5.33±0.44 to 6.54±0.35 (p≤0.05), respectively in 70.83% of study population. Significant improvement (p≤0.05) was also seen in logical memory, memory related to personal life and also in visual as well as auditory memory. BacoMind® was also found to be well tolerable with no major side effects. The findings of the current study revealed the cognitive enhancing effect of the BacoMind® in children requiring individual education programme.